New online tool aims to ease prostate cancer treatment choices
NCT ID NCT07280897
First seen Jan 11, 2026 · Last updated Jun 20, 2026 · Updated 27 times
Summary
This study tests a web-based program called SCIPI that provides easy-to-understand information and tools to help men with localized prostate cancer make treatment decisions. About 200 newly diagnosed patients will be randomly assigned to use SCIPI or receive usual care. Researchers will measure whether SCIPI improves satisfaction with decisions and quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The University of Texas Health Science Center at San Antonio School of Nursing
San Antonio, Texas, 78229, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
SCIPI (Support, Communication, and Information Program for Prostate Cancer - Interactive) – a web-based supportive care program
What this could lead to
If it works, this could provide a simple online tool to help men with prostate cancer feel more confident and satisfied with their treatment choices.
What could go wrong
This is a small pilot study, so results may not apply to everyone. The program may not improve decision-making or quality of life more than usual care.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.